Myopia and Presbyopia Treatment Market Report 2026

Myopia and Presbyopia Treatment Market Overview

• Myopia and Presbyopia Treatment market size has reached to $22.63 billion in 2025 • Expected to grow to $33.57 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: Rising Incidence Of Vision Impairment Drives The Growth Of Myopia And Presbyopia Treatment Market • Market Trend: Innovative Myopia-Combating Sun Spectacle Lenses Revolutionize The Myopia And Presbyopia Treatment Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Myopia and Presbyopia Treatment Market?

Myopia and presbyopia treatment refers to the treatment or procedure to correct and sharpen the vision caused by myopia and presbyopia in adults and children. The key objective of myopia and presbyopia treatment is to diagnose underlying disorders, lower the risk of injury, prevent ocular symptoms, and detect the disease early. The main disease type of myopia and presbyopia treatment are myopia are presbyopia. Myopia is a condition in which visual images focus in front of the retina of the eye, reducing vision of distant objects. Myopia and presbyopia treatments are used to treat myopia in both adults and children. The different myopia treatment types are corrective, surgical and drugs and various presbyopia treatment type are prescription lenses, contact lenses, intraocular lenses and refractive surgery.

What Is The Myopia and Presbyopia Treatment Market Growth Forecast?

The myopia and presbyopia treatment market size is expected to see strong growth in the next few years. It will grow to $33.57 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to growing demand for advanced surgical solutions, increasing adoption of presbyopia-correcting lenses, rising use of pharmacological treatments, technological innovations in eye care diagnostics, expansion of preventive screening programs. Major trends in the forecast period include increasing adoption of multifocal and advanced contact lenses, rising demand for laser and refractive surgical procedures, growing preference for orthokeratology (ortho-k) in myopia control, higher utilization of pharmacological eye drops for presbyopia, expansion of early vision screening and preventive care programs.

Global Myopia and Presbyopia Treatment Market Segmentation

1) By Type: Myopia, Presbyopia 2) By Age Group: Children And Young Adults, Adults, Geriatrics 3) By End-Use: Hospitals, Eye Care Clinics Or Ophthalmic Centers Subsegments: 1) By Myopia: Pharmacological Treatments, Orthokeratology Lenses, Refractive Surgery, Spectacles And Contact Lenses 2) By Presbyopia: Multifocal Lenses, Monovision Contact Lenses, Corneal Inlays, Presbyopia-Correcting Surgery

What Is The Driver Of The Myopia and Presbyopia Treatment Market?

The rising incidence of vision impairment is expected to boost the growth of the myopia and presbyopia treatment market going forward. Vision impairment refers to a condition in which an individual's ability to see and interpret visual information is significantly reduced, leading to difficulties in perceiving and understanding the surrounding environment. The growing incidence of vision impairment can spur the myopia and presbyopia treatment development, leading to increased awareness, innovation, investments, improved access to treatments, and ultimately better outcomes for those seeking solutions for their vision issues. For instance, in August 2023, according to the World Health Organization (WHO), a Switzerland-based United Nations agency, global estimates indicate that 2.2 billion people have near or distance vision impairment, including 1 billion cases that are preventable or untreated, while refractive errors and cataracts remain the leading global causes of vision loss, and only 36% of individuals with refractive-error–related distance impairment and just 17% of those with cataract-related impairment have received appropriate care. Therefore, the rising incidence of vision impairment is driving the growth of the myopia and presbyopia treatment industry.

Key Players In The Global Myopia and Presbyopia Treatment Market

Major companies operating in the myopia and presbyopia treatment market are ALCON Inc., Bausch & Lomb Incorporated, Carl Zeiss AG, Essilor Ltd., Johnson & Johnson Vision Inc., Nidek Corporation, Topcon Corporation, Zimmer Ophthalmic Systems AG, AbbVie Inc., Orasis Pharmaceuticals Ltd., The Cooper Companies Inc., Staar Surgical Co., Eyenovia Inc., Allergan PLC, Hoya Corporation, Menicon Co. Ltd., CooperVision Inc., Visioneering Technologies Inc., AcuFocus Inc., Ocular Therapeutix Inc., SightGlass Vision Inc., Presbia PLC, LensGen Inc., RxSight Inc., Perfect Lens LLC

Global Myopia and Presbyopia Treatment Market Trends and Insights

Major companies operating in the myopia and presbyopia treatment market are developing innovative products, such as myopia combating sun spectacle lenses, to meet larger customer bases, making more sales, and increasing revenue. Myopia-combating sun spectacle lenses refer to eyeglass lenses designed to help mitigate the progression of myopia, also known as near-sightedness, when worn in outdoor or bright sunlight conditions. For instance, in May 2023, HOYA, a Thailand-based optical technology company, launched MiYOSMART sun spectacle lenses to combat myopia in children. MiYOSMART's distinctive feature lies in its innovative approach to slowing down myopia progression in children while providing protection from intense sunlight. This is achieved through two specialized lens options, the photochromic spectacle lenses, MiYOSMART Chameleon, and the polarized spectacle lenses, MiYOSMART Sunbird, both incorporating DIMS Technology (Defocus Incorporated Multiple Segments). Developed in collaboration with the Hong Kong Polytechnic University, DIMS Technology operates on the concept of creating simultaneous defocus during both distance and near viewing. This involves one plane on the retina due to the single vision zone(s) of the lens, while another plane creates myopic defocus through the use of +3.50D defocus lenslets.

What Are Latest Mergers And Acquisitions In The Myopia and Presbyopia Treatment Market?

In January 2024, Eyenovia Inc., a US-based ophthalmic pharmaceutical technology, acquired the development and commercialization rights of MicroPine from Bausch + Lomb Ireland Limited for an undisclosed amount. The aim of the acquisition is to expedite the commercialization of advanced ophthalmic products, specifically targeting pediatric progressive myopia, thereby expanding their late-stage pipeline and addressing a significant unmet medical need in the U.S. and Canada. Bausch + Lomb Ireland Limited is an Ireland-based eye health business engaged in the development of MicroPine for myopia treatment.

Regional Outlook

North America was the largest region in the myopia and presbyopia treatment market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Myopia and Presbyopia Treatment Market?

The myopia and presbyopia treatment market includes revenues earned by entities by performing refractive surgery, lens implants, bifocal surgery services and providing eyesight management treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Myopia and Presbyopia Treatment Market Report 2026?

The myopia and presbyopia treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the myopia and presbyopia treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.